Devon Energy vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Devon Energy

LeaderEnergy & Utilities

Enterprise

Oklahoma City multi-basin oil & gas E&P (NYSE: DVN) ~$14B revenue; Permian Delaware Basin + Williston Bakken (Grayson Mill $5B acquisition), fixed+variable dividend pioneer, $1B FCF improvement plan competing with ConocoPhillips.

AI VisibilityBeta
Overall Score
A92
Category Rank
#182 of 290
AI Consensus
57%
Trend
stable
Per Platform
ChatGPT
89
Perplexity
83
Gemini
99

About

Devon Energy Corporation is an Oklahoma City, Oklahoma-based oil and natural gas exploration and production company — publicly traded on the New York Stock Exchange (NYSE: DVN) as an S&P 500 Energy component — operating primarily in the Permian Basin (Delaware Basin, Texas and New Mexico), Anadarko Basin (Oklahoma), Eagle Ford (South Texas), Powder River Basin (Wyoming), and Williston Basin (North Dakota), with approximately 1,700 employees producing approximately 750,000-800,000 barrels of oil equivalent per day. Devon announced a comprehensive business optimization plan targeting $1 billion in annual pre-tax free cash flow improvements by year-end 2026, focusing on improving margins and capital efficiency across operations — including well productivity optimization, overhead cost reduction, and marketing contract improvements. Devon acquired Grayson Mill Energy (a Williston Basin Bakken shale operator) in 2024 for approximately $5 billion in cash and stock, adding high-quality Williston Basin production that complements Devon's existing Permian Basin core position. Devon pioneered the "fixed plus variable dividend" model in the E&P sector — paying a base quarterly dividend plus a variable dividend linked to free cash flow generation each quarter — a capital return structure that has since been adopted by numerous E&P companies as a shareholder-friendly alternative to buybacks-only programs.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.